rewirebio.iobenchmarks
Dataset

Livesey and Marsh 2025 human DMS benchmark set (36 proteins)

One deep mutational scanning score set per protein for 36 human proteins, with variants present in ClinVar or gnomAD removed.

Evaluation results

485 evaluations · 582 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: 3Cnet (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
7.05% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV96)

Independent external evaluation · Source checked
Methods, coverage and source

3Cnet: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU96 (row '3Cnet', column 'rank_score')
Configuration: 3Cnet (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
0% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

3Cnet: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW96 (row '3Cnet', column 'top_5_winrate')
Configuration: AlphaMissense (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
90.7% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV3)

Independent external evaluation · Source checked
Methods, coverage and source

AlphaMissense: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU3 (row 'AlphaMissense', column 'rank_score')
Configuration: AlphaMissense (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
65.3% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaMissense: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW3 (row 'AlphaMissense', column 'top_5_winrate')
Configuration: AlphScore (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
33.5% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV76)

Independent external evaluation · Source checked
Methods, coverage and source

AlphScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU76 (row 'AlphScore', column 'rank_score')
Configuration: AlphScore (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
11% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW76 (row 'AlphScore', column 'top_5_winrate')
Configuration: BayesDel_noAF (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
57.1% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV39)

Independent external evaluation · Source checked
Methods, coverage and source

BayesDel_noAF: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU39 (row 'BayesDel_noAF', column 'rank_score')
Configuration: BayesDel_noAF (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
6% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDel_noAF: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW39 (row 'BayesDel_noAF', column 'top_5_winrate')
Configuration: BayesDel (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
56.9% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV40)

Independent external evaluation · Source checked
Methods, coverage and source

BayesDel: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU40 (row 'BayesDel', column 'rank_score')
Configuration: BayesDel (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
5.44% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDel: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW40 (row 'BayesDel', column 'top_5_winrate')
Configuration: BLOSUM62 (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
14.9% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV87)

Independent external evaluation · Source checked
Methods, coverage and source

BLOSUM62: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU87 (row 'BLOSUM62', column 'rank_score')
Configuration: BLOSUM62 (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
1.11% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BLOSUM62: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW87 (row 'BLOSUM62', column 'top_5_winrate')
Configuration: CADD_1.6 (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
35% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV75)

Independent external evaluation · Source checked
Methods, coverage and source

CADD_1.6: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU75 (row 'CADD_1.6', column 'rank_score')
Configuration: CADD_1.6 (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
1.22% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CADD_1.6: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW75 (row 'CADD_1.6', column 'top_5_winrate')
Configuration: CADD_1.7 (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
40.3% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV70)

Independent external evaluation · Source checked
Methods, coverage and source

CADD_1.7: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU70 (row 'CADD_1.7', column 'rank_score')
Configuration: CADD_1.7 (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
2.89% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CADD_1.7: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW70 (row 'CADD_1.7', column 'top_5_winrate')
Configuration: CAPICE (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
29.4% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV77)

Independent external evaluation · Source checked
Methods, coverage and source

CAPICE: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU77 (row 'CAPICE', column 'rank_score')
Configuration: CAPICE (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
3.69% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CAPICE: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW77 (row 'CAPICE', column 'top_5_winrate')
Configuration: CARP (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
76.1% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 28/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV17)

Independent external evaluation · Source checked
Methods, coverage and source

CARP: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU17 (row 'CARP', column 'rank_score')
Configuration: CARP (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
20% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CARP: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW17 (row 'CARP', column 'top_5_winrate')
Configuration: ClinPred (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
63.2% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV32)

Independent external evaluation · Source checked
Methods, coverage and source

ClinPred: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU32 (row 'ClinPred', column 'rank_score')
Configuration: ClinPred (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
4.36% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

ClinPred: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW32 (row 'ClinPred', column 'top_5_winrate')
Configuration: CONDEL (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
47.5% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 36/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV57)

Independent external evaluation · Source checked
Methods, coverage and source

CONDEL: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU57 (row 'CONDEL', column 'rank_score')
Configuration: CONDEL (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
9.76% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CONDEL: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW57 (row 'CONDEL', column 'top_5_winrate')
Configuration: CPT-1 (Livesey and Marsh 2025)Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins)
92.8% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)
percent · higher

Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed

Coverage: 29/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV2)

Independent external evaluation · Source checked
Methods, coverage and source

CPT-1: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets

Aggregation: Not reported

Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU2 (row 'CPT-1', column 'rank_score')

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-10-22-1b7cf027e4f6 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

18 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance
Access
DMS and VEP predictions deposited at figshare doi:10.6084/m9.figshare.28295198 (Data availability); not retrieved in this pass.
Context-only references
Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)

Original source ↗

Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: PMC12016141 (published 2025-04-22; Genome Biol 26:104)
Retrieved: 2026-10-14T13:36:01Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.access

Source artifact SHA-256: 1735ee461ef192d9de67c914e9ad73d72d8aa255ea0e3479eb68cd8631d99fa2

Hash scope: Hash scope not separately documented; inspect source record

Access
DMS and VEP predictions deposited at figshare doi:10.6084/m9.figshare.28295198 (Data availability); not retrieved in this pass.
Context-only references
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8)

Original source ↗

Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 13059_2025_3575_MOESM2_ESM.xlsx as published with PMC12016141
Retrieved: 2026-10-14T13:36:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.access

Source artifact SHA-256: 1b0d792d1a5d3daa95545a7973cabb131c45e42c952e7e5a447a72deef1d1e70

Hash scope: Hash scope not separately documented; inspect source record

Assay
Mixed: growth, complementation, binding, abundance (VAMP-seq), reporter and enzyme-activity assays, classed by the authors as direct or indirect (Table S1).
Context-only references
Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)

Original source ↗

Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: PMC12016141 (published 2025-04-22; Genome Biol 26:104)
Retrieved: 2026-10-14T13:36:01Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 1735ee461ef192d9de67c914e9ad73d72d8aa255ea0e3479eb68cd8631d99fa2

Hash scope: Hash scope not separately documented; inspect source record

Assay
Mixed: growth, complementation, binding, abundance (VAMP-seq), reporter and enzyme-activity assays, classed by the authors as direct or indirect (Table S1).
Context-only references
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8)

Original source ↗

Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 13059_2025_3575_MOESM2_ESM.xlsx as published with PMC12016141
Retrieved: 2026-10-14T13:36:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 1b0d792d1a5d3daa95545a7973cabb131c45e42c952e7e5a447a72deef1d1e70

Hash scope: Hash scope not separately documented; inspect source record

Population
36 human proteins, 207,460 single amino acid variants (Results). Per protein, the score set with the highest median Spearman correlation with all VEPs was chosen; datasets with fewer than 1000 scored substitutions after removing ClinVar and gnomAD variants, antibody-binding assays, the ACE2 to SARS-CoV-2 binding assay and datasets without methodological details were excluded. GCH1 is an unpublished dataset used with the authors' permission.
Context-only references
Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)

Original source ↗

Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: PMC12016141 (published 2025-04-22; Genome Biol 26:104)
Retrieved: 2026-10-14T13:36:01Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 1735ee461ef192d9de67c914e9ad73d72d8aa255ea0e3479eb68cd8631d99fa2

Hash scope: Hash scope not separately documented; inspect source record

Population
36 human proteins, 207,460 single amino acid variants (Results). Per protein, the score set with the highest median Spearman correlation with all VEPs was chosen; datasets with fewer than 1000 scored substitutions after removing ClinVar and gnomAD variants, antibody-binding assays, the ACE2 to SARS-CoV-2 binding assay and datasets without methodological details were excluded. GCH1 is an unpublished dataset used with the authors' permission.
Context-only references
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8)

Original source ↗

Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 13059_2025_3575_MOESM2_ESM.xlsx as published with PMC12016141
Retrieved: 2026-10-14T13:36:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 1b0d792d1a5d3daa95545a7973cabb131c45e42c952e7e5a447a72deef1d1e70

Hash scope: Hash scope not separately documented; inspect source record

Source location
Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability
Context-only references
Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)

Original source ↗

Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: PMC12016141 (published 2025-04-22; Genome Biol 26:104)
Retrieved: 2026-10-14T13:36:01Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 1735ee461ef192d9de67c914e9ad73d72d8aa255ea0e3479eb68cd8631d99fa2

Hash scope: Hash scope not separately documented; inspect source record

Source location
Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability
Context-only references
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8)

Original source ↗

Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 13059_2025_3575_MOESM2_ESM.xlsx as published with PMC12016141
Retrieved: 2026-10-14T13:36:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 1b0d792d1a5d3daa95545a7973cabb131c45e42c952e7e5a447a72deef1d1e70

Hash scope: Hash scope not separately documented; inspect source record

Species
Homo sapiens
Context-only references
Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)

Original source ↗

Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: PMC12016141 (published 2025-04-22; Genome Biol 26:104)
Retrieved: 2026-10-14T13:36:01Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.species

Source artifact SHA-256: 1735ee461ef192d9de67c914e9ad73d72d8aa255ea0e3479eb68cd8631d99fa2

Hash scope: Hash scope not separately documented; inspect source record

Species
Homo sapiens
Context-only references
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8)

Original source ↗

Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 13059_2025_3575_MOESM2_ESM.xlsx as published with PMC12016141
Retrieved: 2026-10-14T13:36:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.species

Source artifact SHA-256: 1b0d792d1a5d3daa95545a7973cabb131c45e42c952e7e5a447a72deef1d1e70

Hash scope: Hash scope not separately documented; inspect source record

How to read the evidence

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: vep-lit-20261014-dataset-livesey2025-dms-36

areas
proteins-complexes
contexts
research
population
36 human proteins, 207,460 single amino acid variants (Results). Per protein, the score set with the highest median Spearman correlation with all VEPs was chosen; datasets with fewer than 1000 scored substitutions after removing ClinVar and gnomAD variants, antibody-binding assays, the ACE2 to SARS-CoV-2 binding assay and datasets without methodological details were excluded. GCH1 is an unpublished dataset used with the authors' permission.
variant count
207460
split
No training split; zero-shot comparison of VEP scores with DMS scores. For Envision, CPT-1, DeMaSk, VARITY_R and VARITY_ER the DMS sets used to train them are excluded from their comparisons (Table S2).
assay
Mixed: growth, complementation, binding, abundance (VAMP-seq), reporter and enzyme-activity assays, classed by the authors as direct or indirect (Table S1).
species
Homo sapiens
access
DMS and VEP predictions deposited at figshare doi:10.6084/m9.figshare.28295198 (Data availability); not retrieved in this pass.
source locator
Results 'New DMS datasets and VEPs'; Methods 'DMS datasets'; Table 1; Supplementary Table S1; Data availability
missing metadata
version: reason: unreported; note: No dataset version beyond the paper; the figshare deposit was not retrieved.
review
reviewer: claude; reviewer note: Claude review agent; no human review claimed. Independent Claude (Opus 5.5) review agent, separate from the extraction agent that built this batch. Automated review only. Transcription, not reproduction.; reviewed at: 2026-10-14T15:30:00Z; artifact sha256: 1735ee461ef192d9de67c914e9ad73d72d8aa255ea0e3479eb68cd8631d99fa2; retrieval url: https://www.ebi.ac.uk/europepmc/webservices/rest/PMC12016141/fullTextXML; method: ai-assisted-source-review; scope-review; method note: Descriptive fields, identity links and missing-metadata reasons checked against the cited sources.; note: Checked; see the dated review for rulings on identity and method type.
Related records

Suggest a correction